CBT Cabot Corporation
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through two segments, Reinforcement Materials and Performance Chemicals. The company offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions. It also provides specialty carbons for use in inks, coatings, plastics, adhesives, toners, batteries, and displays; conductive additives and fumed alumina used in lead acid and lithium-ion batteries for electric vehicles; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; and fumed alumina for use in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries. In addition, it offers aerogel, a hydrophobic, silica-based particle to use in various thermal insulation and specialty chemical applications; masterbatch and conductive compound products that are used in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; and inkjet colorants for inkjet printing applications, as well as carbon nanotubes and fumed metal oxides. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.…
Industry Peers
Specialty ChemicalsKey Statistics
About Cabot (NYSE: CBT)
›
Cabot (NYSE: CBT) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector.
The shares were at 72.83 USD on 19 November 2026, up 19.8% over 52 weeks. Its 52-week range is 58.33 USD to 94.53 USD: the price is 23.0% below the high and 24.9% above the low.
At a market capitalisation of 3.74B USD, it trades at 18.1 times trailing earnings and 9.8 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.0, a discount of 47% for CBT. It pays a dividend yielding 2.55% (it pays out 51% of its earnings), against a median of 1.76% among the dividend payers in that peer group.
Cabot reports return on equity of 14.2%, an operating margin of 14.9% and revenue up 12.2% year over year.
Its debt exceeds its cash by 998.00M USD, a debt-to-equity ratio of 0.78. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 6 analysts cover the stock, with an average rating of Hold; their mean price target of 85.33 USD is 17.2% above the current price. The next earnings report is expected on 1 February 2027.